Mass spectrometric detection of the plasma prealbumin (transthyretin) variant associated with familial amyloidotic polyneuropathy. 1986

Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi

A plasma prealbumin variant with a methionine-for-valine substitution at position 30 is closely associated with familial amyloidotic polyneuropathy (FAP) type I. Secondary ion mass spectrometry of the tryptic digest of a carrier's prealbumin could easily detect an abnormal peptide containing the substitution besides the normal peptide. This is a sensitive and reliable method for the diagnosis of FAP.

UI MeSH Term Description Entries
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011228 Prealbumin A tetrameric protein, molecular weight between 50,000 and 70,000, consisting of 4 equal chains, and migrating on electrophoresis in 3 fractions more mobile than serum albumin. Its concentration ranges from 7 to 33 per cent in the serum, but levels decrease in liver disease. Proalbumin,Transthyretin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
January 1985, The Journal of clinical investigation,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
October 1986, The Journal of clinical investigation,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
October 1983, The Journal of laboratory and clinical medicine,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
July 1986, The Journal of laboratory and clinical medicine,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
March 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
January 1988, Advances in neurology,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
April 1987, Neurology,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
May 1994, No to shinkei = Brain and nerve,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
February 1996, No to shinkei = Brain and nerve,
Y Wada, and T Matsuo, and I Katakuse, and T Suzuki, and T Azuma, and S Tsujino, and S Kishimoto, and H Matsuda, and A Hayashi
April 1989, Molecular biology & medicine,
Copied contents to your clipboard!